# Organon (OGN) — Earnings

OGN · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/ogn/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q1 2026 |
| Period end | Mar 31, 2026 |
| EPS actual | $0.71 |
| EPS estimate | $0.83 |
| EPS surprise | −14.32% |
| Revenue surprise | −1.85% |
| Revenue | $1.5B |
| Revenue estimate | $1.5B |
| Reported | Apr 30, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1821825/000162828026029532/ogn-20260331.htm) |

Organon reported Q1 2026 results on April 30, 2026. Earnings per share were $0.71, short of the $0.83 estimate by 14.32%. Revenue was $1.5 billion, 1.85% below a consensus that also rounds to $1.5 billion. Compared with Q1 2025, EPS fell about 30% from $1.02, while revenue was unchanged at the rounded $1.5 billion.

This was the second miss in a row. Q4 2025 came in at $0.63 against a $0.73 estimate, the lowest EPS in the table. Annual EPS has declined each year, from $5.03 in 2022 to $4.14 in 2023, $4.11 in 2024 and $3.66 in 2025, about 27% lower over three years. Revenue stayed between $6.2 billion and $6.4 billion a year over the same span. The highest quarterly EPS in the table came early, at $1.68 in Q2 2021 and $1.67 in Q3 2021. Organon beat the EPS estimate in 14 of the last 20 quarters, but revenue topped the consensus only 3 times.

Q2 results came between August 4 and August 12 in each of the past five years. The table does not yet include a Q2 2026 report, so the next update will show results for that quarter.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q1 2026 | Apr 30, 2026 | $0.83 | $0.71 | -14.32% | $1.5B | $1.5B |
| Q4 2025 | Feb 12, 2026 | $0.73 | $0.63 | -13.34% | $1.5B | $1.5B |
| Q3 2025 | Nov 10, 2025 | $0.94 | $1.01 | 7.94% | $1.6B | $1.6B |
| Q2 2025 | Aug 5, 2025 | $0.95 | $1.00 | 5.43% | $1.6B | $1.6B |
| Q1 2025 | May 1, 2025 | $0.89 | $1.02 | 14.09% | $1.5B | $1.5B |
| Q4 2024 | Feb 13, 2025 | $0.87 | $0.90 | 3.79% | $1.6B | $1.6B |
| Q3 2024 | Oct 31, 2024 | $0.90 | $0.87 | -3.70% | $1.6B | $1.6B |
| Q2 2024 | Aug 6, 2024 | $1.08 | $1.12 | 4.13% | $1.6B | $1.6B |
| Q1 2024 | May 2, 2024 | $0.98 | $1.22 | 24.76% | $1.6B | $1.6B |
| Q4 2023 | Feb 15, 2024 | $0.81 | $0.88 | 8.51% | $1.6B | $1.6B |
| Q3 2023 | Nov 2, 2023 | $1.05 | $0.87 | -17.17% | $1.6B | $1.5B |
| Q2 2023 | Aug 8, 2023 | $0.97 | $1.31 | 34.68% | $1.6B | $1.6B |
| Q1 2023 | May 4, 2023 | $1.17 | $1.08 | -7.35% | $1.5B | $1.5B |
| Q4 2022 | Feb 16, 2023 | $0.92 | $0.81 | -11.96% | $1.5B | $1.5B |
| Q3 2022 | Nov 3, 2022 | $1.10 | $1.32 | 19.85% | $1.5B | $1.5B |
| Q2 2022 | Aug 4, 2022 | $1.17 | $1.25 | 6.57% | $1.5B | $1.6B |
| Q1 2022 | May 5, 2022 | $1.30 | $1.65 | 26.79% | $1.5B | $1.6B |
| Q4 2021 | Feb 17, 2022 | $1.24 | $1.37 | 10.23% | $1.6B | $1.6B |
| Q3 2021 | Nov 12, 2021 | $1.44 | $1.67 | 15.99% | $1.6B | $1.6B |
| Q2 2021 | Aug 12, 2021 | $1.42 | $1.68 | 18.61% | $1.5B | $1.6B |

## Frequently Asked Questions

### When did Organon (OGN) last report earnings?

Organon last reported on Apr 30, 2026, covering fiscal Q1 2026.

### Did OGN beat earnings estimates?

No. Organon reported EPS of $0.71 for Q1 2026 against a $0.83 estimate — a 14.32% miss.

### How much revenue did OGN report last quarter?

Organon reported $1.5B in revenue for Q1 2026, against a consensus estimate of $1.5B.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).